Nuclear Medicine Blog

Nuke-Tek by Ann Marie Alessi

Biodex announces the release of its NEW 2014 Nuclear Medicine and Molecular Imaging Supplies and Accessories Catalog with up-to-date content and detailed product information.

December 23, 2013
Ann Marie Alessi, BS, CNMT, NCT, RT(N), FSNMMI-TS, Product Sales Manager, Nuclear Medicine, Biodex Medical Systems, Inc.

Nuclear Catalog #119

There are exciting new products and upgrades to existing products that we are sure you will find interesting. We have added a Clear-Lead™ Mobile Radiation Barrier and a Tabletop Shield to our shielding and storage product line.  Both provide optimum protection from radiation, making them must haves for any nuclear medicine department. >>


Nuke-Tek by Ann Marie Alessi

Radioaerosol Studies in Ventilator Assisted Patients

December 5, 2013
Ann Marie Alessi, BS, CNMT, NCT, RT(N), FSNMMI-TS, Product Sales Manager, Nuclear Medicine, Biodex Medical Systems, Inc.

Radioaerosol inhalation lung scanning in ventilator assisted patients is not only feasible but a valuable tool that can lead to important changes in patient management. However, in these patients, radioaerosols have been less readily accepted. It generally has been felt that the central bronchial deposition and poor peripheral penetration tendencies of radioaerosols are likely to be accentuated in this patient group. With technical improvements in current delivery systems, this appears to be less of a problem and has resulted in substantially increased clinical utilization in this patient population.. >>

Nuke-Tek by Ann Marie Alessi

USP<797> Requirements for Radiopharmaceuticals

November 26, 2013
Ann Marie Alessi, BS, CNMT, NCT, RT(N), FSNMMI-TS, Product Sales Manager, Nuclear Medicine, Biodex Medical Systems, Inc.

The section in USP <797> addressing the requirements for radiopharmaceuticals as Compounded Sterile Preparations (CSPs) is based on specific and detailed recommendations from an advisory panel of nuclear pharmacists. This section clarifies details and exemptions for radiopharmaceutical compounding, especially in regards to microbial contamination risk levels.

Determining the risk level of CSPs prepared in a nuclear pharmacy is one of the most important aspects of the section. Keep in mind that both radionuclides and non-radioactive medications are handled, prepared, and stored in nuclear pharmacies. Table 1 provides a list of common radionuclides and traditional drugs that are prepared and dispensed with their corresponding risk levels.>>

Nuke-Tek by Ann Marie Alessi

Low-Energy Photon Emitters

October 25, 2013
Ann Marie Alessi, BS, CNMT, NCT, RT(N), FSNMMI-TS, Product Sales Manager, Nuclear Medicine, Biodex Medical Systems, Inc.

A number of commonly used radionuclides emit relatively abundant characteristic x-rays (low energy peak) in addition to their principal photons. The characteristic x-rays from these radionuclides have energies that fall within the peak and potentially contribute a large component to the ionization current. If the source container is glass, the x-rays may be highly absorbed in the glass wall. If the container is a capsule or plastic syringe, a significant number of the x-rays will penetrate to the sensitive volume of the chamber. >>

Heads up on a change in Thyroid Imaging Codes

March 8, 2013
http://www.hcpro.com

The AMA made numerous revisions to the nuclear medicine and diagnostic endocrine system subsection for 2013.

Codes 78000-78011 (thyroid imaging codes) were deleted and replaced with three new bundled thyroid imaging codes  >>

 
View Full Site

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Read More